GURUFOCUS.COM » STOCK LIST » Industrials » Industrial Products » Enovix Corp (NAS:ENVX) » Definitions » ROE %

Enovix (Enovix) ROE % : -93.97% (As of Dec. 2023)


View and export this data going back to 2021. Start your Free Trial

What is Enovix ROE %?

ROE % is calculated as Net Income divided by its average Total Stockholders Equity over a certain period of time. Enovix's annualized net income for the quarter that ended in Dec. 2023 was $-239.91 Mil. Enovix's average Total Stockholders Equity over the quarter that ended in Dec. 2023 was $255.31 Mil. Therefore, Enovix's annualized ROE % for the quarter that ended in Dec. 2023 was -93.97%.

The historical rank and industry rank for Enovix's ROE % or its related term are showing as below:

ENVX' s ROE % Range Over the Past 10 Years
Min: -109.48   Med: -69.57   Max: -15.13
Current: -75.04

During the past 4 years, Enovix's highest ROE % was -15.13%. The lowest was -109.48%. And the median was -69.57%.

ENVX's ROE % is ranked worse than
96.95% of 2954 companies
in the Industrial Products industry
Industry Median: 7.105 vs ENVX: -75.04

Enovix ROE % Historical Data

The historical data trend for Enovix's ROE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enovix ROE % Chart

Enovix Annual Data
Trend Dec20 Dec21 Dec22 Dec23
ROE %
-109.48 -69.48 -15.13 -69.66

Enovix Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
ROE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -12.52 -88.08 -91.97 -25.91 -93.97

Competitive Comparison of Enovix's ROE %

For the Electrical Equipment & Parts subindustry, Enovix's ROE %, along with its competitors' market caps and ROE % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enovix's ROE % Distribution in the Industrial Products Industry

For the Industrial Products industry and Industrials sector, Enovix's ROE % distribution charts can be found below:

* The bar in red indicates where Enovix's ROE % falls into.



Enovix ROE % Calculation

Enovix's annualized ROE % for the fiscal year that ended in Dec. 2023 is calculated as

ROE %=Net Income (A: Dec. 2023 )/( (Total Stockholders Equity (A: Dec. 2022 )+Total Stockholders Equity (A: Dec. 2023 ))/ count )
=-214.071/( (356.427+258.147)/ 2 )
=-214.071/307.287
=-69.66 %

Enovix's annualized ROE % for the quarter that ended in Dec. 2023 is calculated as

ROE %=Net Income (Q: Dec. 2023 )/( (Total Stockholders Equity (Q: Sep. 2023 )+Total Stockholders Equity (Q: Dec. 2023 ))/ count )
=-239.908/( (252.475+258.147)/ 2 )
=-239.908/255.311
=-93.97 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROE %, the net income of the last fiscal year and the average total shareholder equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (Dec. 2023) net income data. ROE % is displayed in the 30-year financial page.


Enovix  (NAS:ENVX) ROE % Explanation

ROE % measures the rate of return on the ownership interest (shareholder's equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' equity (also known as net assets or assets minus liabilities). ROE % shows how well a company uses investment funds to generate earnings growth. ROE %s between 15% and 20% are considered desirable.

The factors that affect a company's ROE % can be illustrated with the three-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-239.908/255.311
=(Net Income / Revenue )*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-239.908 / 29.524)*(29.524 / 542.123)*(542.123 / 255.311)
=Net Margin %*Asset Turnover*Equity Multiplier
=-812.59 %*0.0545*2.1234
=ROA %*Equity Multiplier
=-44.29 %*2.1234
=-93.97 %

With this breakdown, it is clear that if a company grows its Net Profit Margin, its Asset Turnover, or its Leverage, it can grow its ROE %.

The factors that affect a company's ROE % can also be illustrated with the five-step DuPont Analysis:

ROE %(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-239.908/255.311
=(Net Income / Pre-Tax Income) * (Pre-Tax Income / Operating Income) * (Operating Income / Revenue) * (Revenue / Total Assets) * (Total Assets / Total Stockholders Equity)
= (-239.908 / -242.684) * (-242.684 / -259.108) * (-259.108 / 29.524) * (29.524 / 542.123) * (542.123 / 255.311)
= Tax Burden * Interest Burden * Operating Margin % * Asset Turnover * Equity Multiplier
= 0.9886 * 0.9366 * -877.62 % * 0.0545 * 2.1234
=-93.97 %

Note: The net income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data. The same rule applies to Pre-Tax Income and Operating Income.
* In the five-step DuPont Analysis, Operating Income is only available for non-financial companies. Thus, for Insurance companies, we use EBIT as a substitution of Operating Income. For Banks, both Operating Income and EBIT is unavailable. Thus we combined Interest Burden and Operating Margin % into Pretax Margin %, and the DuPont Analysis is divided into four components instead.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Net Income is used.

Because a company can increase its ROE % by having more financial leverage, it is important to watch the equity multiplier when investing in high ROE % companies. Like ROA %, ROE % is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their ROE %s can be extremely high.


Enovix ROE % Related Terms

Thank you for viewing the detailed overview of Enovix's ROE % provided by GuruFocus.com. Please click on the following links to see related term pages.


Enovix (Enovix) Business Description

Traded in Other Exchanges
Address
3501 W. Warren Avenue, Fremont, CA, USA, 94538
Enovix Corp is engaged in the business of advanced silicon-anode lithium-ion battery development and production. It is also developing its 3D cell technology and production process for the electric vehicle and energy storage markets to help enable the widespread utilization of renewable energy.
Executives
Rajendra K Talluri director, officer: President and CEO 3501 W. WARREN AVENUE, FREMONT CA 94538
Betsy S Atkins director
Arthi Chakravarthy officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Farhan Ahmad officer: Chief Financial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Bernard Gutmann director ON SEMICONDUCTOR C/O V PECORA (M/D A700), 5005 EAST MCDOWELL ROAD, PHOENIX AZ 85008
Ralph H Schmitt officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Thurman J Rodgers director, 10 percent owner 535 EASTVIEW WAY, WOODSIDE CA 94062
Ashok Lahiri officer: Chief Technology Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Ajay Marathe officer: Chief Operating Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Harrold J Rust director, officer: President and CEO C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Gardner Cameron Dales officer: Chief Commercial Officer C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Eclipse Fund Iii, L.p. 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
Eclipse Gp Iii, Llc 10 percent owner 514 HIGH STREET, SUITE 4, PALO ALTO CA 94301
J Daniel Mccranie director C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538
Edward J Hejlek officer: See Remarks C/O ENOVIX CORPORATION, 3501 W. WARREN AVENUE, FREMONT CA 94538